Compulsory Maintenance Treatment Program Amongst Iranian Injection Drug Users and Its Side Effects | Zendy

Sharareh Eskandarieh | Zendy; Firoozeh Jafari | Zendy; Somayeh Yazdani | Zendy; Nazanin Hazrati | Zendy; Mohammad Bagher Saberi-Zafarghandi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Compulsory Maintenance Treatment Program Amongst Iranian Injection Drug Users and Its Side Effects

Author(s) -

Sharareh Eskandarieh,

Firoozeh Jafari,

Somayeh Yazdani,

Nazanin Hazrati,

Mohammad Bagher Saberi-Zafarghandi

Publication year - 2014

Publication title -

international journal high risk behaviors and addiction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.266

H-Index - 13

ISSN - 2251-8711

DOI - 10.5812/ijhrba.21765

Subject(s) - methadone maintenance , psychiatry , medicine , drug , mental health , addiction , christian ministry , methadone , harm reduction , addiction treatment , harm , substance abuse , family medicine , public health , psychology , nursing , social psychology , philosophy , theology

Psychoactive substance use can cause a broad variety of mental health disorders and social health problems for the drug users, their family and society.The Ministry of Health, Treatment, and Medical Education of Iran has recently proclaimed an estimated number of 2 million drug abusers and 200,000 injecting drug users (IDUs).For data collection, the directory of mental, social health, and Addiction designed a questionnaire in cooperation with Drug Control Headquarters of Iran.Among 402 IDUs patients, a large amount of them were male, single, and younger than 39 years. Regarding psychotic and somatic symptoms caused by methadone therapy, most of the participants had no problem with methadone maintenance treatment (MMT).There is a need to train health staff, and the community, concerning preventive measures, treatment, and reducing harm for substance drug users.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research